A cinnamic acid derivative
Related Products
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Isoferulic Acid

Item No. 22715

Technical Information
Formal Name
3-(3-hydroxy-4-methoxyphenyl)-2-propenoic acid
CAS Number
537-73-5
Synonyms
  • 3-methoxy Caffeic Acid
  • 3-hydroxy-4-Methoxycinnamic Acid
  • NSC 51987
Molecular Formula
C10H10O4
Formula Weight
Purity
≥98%
Formulation
A crystalline solid
DMF: 20 mg/mLDMF:PBS(pH 7.2)(1:6): 0.14 mg/mLDMSO: 15 mg/mLEthanol: 10 mg/mL
λmax
219, 243, 293, 323 nm
SMILES
O=C(O)/C=C/C1=CC(O)=C(OC)C=C1
InChi Code
InChI=1S/C10H10O4/c1-14-9-4-2-7(6-8(9)11)3-5-10(12)13/h2-6,11H,1H3,(H,12,13)/b5-3+
InChi Key
QURCVMIEKCOAJU-HWKANZROSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Cayman Chemical
    Explore Obesity & Metabolic Disease Resources

    Discover high-quality research tools to investigate GLP-1 mechanisms and next-generation metabolic targets.

    OBESITY RESEARCH SOLUTIONS
    Product Description

    Isoferulic acid is a cinnamic acid derivative that has antidiabetic activity.1,2 It binds to and activates α1-adrenergic receptors (IC50 = 1.4 µM) to enhance secretion of β-endorphin (EC50 = 52.2 nM) and increase glucose use in vitro. Isoferulic acid increases glucose uptake and enhances glycogen synthesis in isolated soleus muscles from streptozocin-induced diabetic rats.3 In vivo, isoferulic acid induces a dose-dependent reduction in plasma glucose levels in streptozocin-induced diabetic rats. It also inhibits absorbance of intestinal maltase and sucrose via α-glucosidase in vitro (IC50s = 760 and 450 µM, respectively).4

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Liu, I.-M., Tsai, C.-C., Lai, T.-Y., et alStimulatory effect of isoferulic acid on α1A-adrenoceptor to increase glucose uptake into cultured myoblast C2C12 cell of mice. Auton. Neurosci. 88(3), 175-180 (2001).

    2. Liu, I.-M., Chen, W.-C., and Cheng, J.-T. Mediation of β-endorphin by isoferulic acid to lower plasma glucose in streptozotocin-induced diabetic rats. J. Pharmacol. Exp. Ther. 307(3), 1196-1204 (2003).

    3. Liu, I.-M., Hsu, F.-L., Chen, C.-F., et alAntihyperglycemic action of isoferulic acid in streptozotocin-induced diabetic rats. Br. J. Pharmacol. 129(4), 631-636 (2000).

    4. Adisakwattana, S., Chantarasinlapin, P., Thammarat, H., et alA series of cinnamic acid derivatives and their inhibitory activity on intestinal alpha-glucosidase. J. Enzyme Inhib. Med. Chem. 24(5), 1194-1200 (2009).